HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 3, 1669-1679, January 18, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/3/1669    most recent M109320200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walters, M. R. Articles by Smith, C. L. Search for Related Content PubMed PubMed Citation Articles by Walters, M. R. Articles by Smith, C. L. Social Bookmarking                      What's this?

SKF-82958 Is a Subtype-selective Estrogen Receptor- (ER) Agonist That Induces Functional Interactions between ER and AP-1^*

Marian R. Walters^§, Martin Dutertre^§¶, and Carolyn L. Smith^§

From the  Department of Physiology, Tulane Medical School, New Orleans, Louisiana 70112 and the ^§ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030

The transcriptional activity of estrogen receptors (ERs) can be regulated by ligands as well as agents such as dopamine, which stimulate intracellular signaling pathways able to communicate with these receptors. We examined the ability of SKF-82958 (SKF), a previously characterized full dopamine D1 receptor agonist, to stimulate the transcriptional activity of ER and ER. Treatment of HeLa cells with SKF-82958 stimulated robust ER-dependent transcription from an estrogen-response element-E1b-CAT reporter in the absence of estrogen, and this was accompanied by increased receptor phosphorylation. However, induction of ER-directed gene expression under the same conditions was negligible. In our cell model, SKF treatment did not elevate cAMP levels nor enhance transcription from a cAMP-response element-linked reporter. Control studies revealed that SKF-82958, but not dopamine, competes with 17-estradiol for binding to ER or ER with comparable relative binding affinities. Therefore, SKF-82958 is an ER-selective agonist. Transcriptional activation of ER by SKF was more potent than expected from its relative binding activity, and further examination revealed that this synthetic compound induced expression of an AP-1 target gene in a tetradecanoylphorbol-13-acetate-response element (TRE)-dependent manner. A putative TRE site upstream of the estrogen-response element and the amino-terminal domain of the receptor contributed to, but were not required for, SKF-induced expression of an ER-dependent reporter gene. Overexpression of the AP-1 protein c-Jun, but not c-Fos, strongly enhanced SKF-induced ER target gene expression but only when the TRE was present. These studies provide information on the ability of a ligand that weakly stimulates ER to yield strong stimulation of ER-dependent gene expression through cross-talk with other intracellular signaling pathways producing a robust combinatorial response within the cell.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Safe and K. Kim Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J. Mol. Endocrinol., November 1, 2008; 41(5): 263 - 275. [Abstract] [Full Text] [PDF]

				T. J. Peterson, S. Karmakar, M. C. Pace, T. Gao, and C. L. Smith The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor {alpha} Transcriptional Activity Mol. Cell. Biol., September 1, 2007; 27(17): 5933 - 5948. [Abstract] [Full Text] [PDF]

				B. M. Jaber, T. Gao, L. Huang, S. Karmakar, and C. L. Smith The Pure Estrogen Receptor Antagonist ICI 182,780 Promotes a Novel Interaction of Estrogen Receptor-{alpha} with the 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein-Binding Protein/p300 Coactivators Mol. Endocrinol., November 1, 2006; 20(11): 2695 - 2710. [Abstract] [Full Text] [PDF]

				Y. Makihara, H. Yamamoto, M. Inoue, K. Tomiyama, N. Koshikawa, and J. L. Waddington Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent J Psychopharmacol, December 1, 2004; 18(4): 484 - 495. [Abstract] [PDF]

				T. L. McCarthy, W.-Z. Chang, Y. Liu, and M. Centrella Runx2 Integrates Estrogen Activity in Osteoblasts J. Biol. Chem., October 31, 2003; 278(44): 43121 - 43129. [Abstract] [Full Text] [PDF]

				M. Dutertre and C. L. Smith Ligand-Independent Interactions of p160/Steroid Receptor Coactivators and CREB-Binding Protein (CBP) with Estrogen Receptor-{alpha}: Regulation by Phosphorylation Sites in the A/B Region Depends on Other Receptor Domains Mol. Endocrinol., July 1, 2003; 17(7): 1296 - 1314. [Abstract] [Full Text] [PDF]

				K. M. Coleman, M. Dutertre, A. El-Gharbawy, B. G. Rowan, N. L. Weigel, and C. L. Smith Mechanistic Differences in the Activation of Estrogen Receptor-alpha (ERalpha )- and ERbeta -dependent Gene Expression by cAMP Signaling Pathway(s) J. Biol. Chem., April 4, 2003; 278(15): 12834 - 12845. [Abstract] [Full Text] [PDF]